Correlation Between Aryx Therapeutics and Moderna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aryx Therapeutics and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aryx Therapeutics and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aryx Therapeutics and Moderna, you can compare the effects of market volatilities on Aryx Therapeutics and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aryx Therapeutics with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aryx Therapeutics and Moderna.

Diversification Opportunities for Aryx Therapeutics and Moderna

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aryx Therapeutics and Moderna is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Aryx Therapeutics and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Aryx Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aryx Therapeutics are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Aryx Therapeutics i.e., Aryx Therapeutics and Moderna go up and down completely randomly.

Pair Corralation between Aryx Therapeutics and Moderna

Given the investment horizon of 90 days Aryx Therapeutics is expected to generate 5.71 times more return on investment than Moderna. However, Aryx Therapeutics is 5.71 times more volatile than Moderna. It trades about 0.11 of its potential returns per unit of risk. Moderna is currently generating about 0.05 per unit of risk. If you would invest  0.49  in Aryx Therapeutics on April 4, 2022 and sell it today you would lose (0.44)  from holding Aryx Therapeutics or give up 89.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aryx Therapeutics  vs.  Moderna

 Performance (%) 
      Timeline 
Aryx Therapeutics 
Aryx Therapeutics Performance
12 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Aryx Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly sluggish basic indicators, Aryx Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Aryx Therapeutics Price Channel

Moderna 
Moderna Performance
0 of 100
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest sluggish performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Moderna Price Channel

Aryx Therapeutics and Moderna Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Aryx Therapeutics and Moderna

The main advantage of trading using opposite Aryx Therapeutics and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aryx Therapeutics position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.
The idea behind Aryx Therapeutics and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Moderna

Pair trading matchups for Moderna

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go